Business Standard

Tuesday, January 07, 2025 | 04:51 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Promius Pharma sells rights of Cloderm cream to EPI Health, LLC: Dr Reddy's

As per terms, Promius Pharma will be paid upfront and get future royalties as consideration for the cream and its generic in the US

Dr Reddy's
Premium

BS Reporter Hyderabad
Dr Reddy's Laboratories Limited announced on Tuesday that its wholly-owned subsidiary Promius Pharma has sold its rights of Cloderm (Clocortolone pivalate) cream, and its authorised generic to EPI Health, LLC.

Under the terms of the agreement, Promius Pharma is eligible to receive an upfront payment followed by future royalties as the consideration for the Cloderm cream and its authorised generic in the US effective immediately, according to the company. EPI group is a privately held company headquartered in Charleston, South Carolina, USA.

"We look forward to EPI continuing to support Cloderm, a brand that providers have prescribed for several decades

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in